Exploring the importance of cancer pathways by meta-analysis of differential protein expression networks in three different cancers

Abstract

BackgroundIt is believed that all cancers occur due to the mutation or change in one or more genes. In order to investigate the significance of the biological pathways which are interrupted by these genetic mutations, we pursue an integrated analysis using multiple cancer datasets released by the International Cancer Genome Consortium (ICGC). This dataset consists of expression profiles for genes/proteins of patients receiving treatment, for three types of cancer - Head and Neck Squamous Cell Carcinoma (HNSC), Lung Adenocarcinoma (LUAD) and Kidney Renal Clear Cell Carcinoma (KIRC). We consider pathway analysis to identify all the biological pathways which are active among the patients and investigate the roles of the significant pathways using a differential network analysis of the protein expression datasets for the three cancers separately. We then integrate the pathway based results of all the three cancers which provide a more comprehensive picture of the three cancers.ResultsFrom our analysis of the protein expression data, overall, RAS and PI3K signaling pathways appear to play the most significant roles in the three cancers - Head and Neck Squamous Cell Carcinoma (HNSC), Lung Adenocarcinoma (LUAD) and Kidney Renal Clear Cell Carcinoma (KIRC).ConclusionThis analysis suggests that the RAS and PI3K signaling pathways are the two most important pathways in all the three cancers and should be investigated further for their potential roles in cancers.ReviewersThis article was reviewed by Joaquin Dopazo and Samiran Ghosh.

Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets

“…Associated genes were FGF2, FGFR2 and FGFR3. A recent study has suggested that PI3K and RAS signaling pathways are the two most important pathways in cancers of the head and neck, lung and kidney (72). In many cancers, PI3K pathway associated genes and proteins have been widely investigated as therapeutic targets (73).…”

A molecular subtype model of ccRCC based on immune-related genes for predicting immunotherapy response

“…In particular, pathways such as NFkB, Trail, EGFR, PI3K, and TNF-α have been found to play signi cant roles in the high-risk group of ccRCC [5][6][7]. Targeting genes and proteins within the PI3K pathway has shown promise as a therapeutic approach for ccRCC, and the EGFR pathway is known to be crucial in the development of ccRCC and represents a potential therapeutic target [7]. Our research identi ed signi cant enrichments in GO and KEGG terms, including small molecule catalytic processes, apical parts of the cell, mesenchymal development, sarcomere, growth factor activity, and MAPK signaling pathway.…”

“…Multiple studies have highlighted the differences in various pathways across different ccRCC subtypes. In particular, pathways such as NFkB, Trail, EGFR, PI3K, and TNF-α have been found to play signi cant roles in the high-risk group of ccRCC [5][6][7]. Targeting genes and proteins within the PI3K pathway has shown promise as a therapeutic approach for ccRCC, and the EGFR pathway is known to be crucial in the development of ccRCC and represents a potential therapeutic target [7].…”

Identification of informative genes and sub-pathways using Improved Differential Expression Analysis for Pathways (iDEAP) for cancer classification

“…34 The Ras signaling pathway is rarely related to HNSCC, but this pathway had been shown to be highly significant to this cancer by a meta-analysis of differential protein expression networks. 35 In this pathway, eight informative genes were selected by the proposed method and all the genes (PIK3CA, PIK3C3, PIK3CG, PIK3CB, PIK3CD, HRAS, NRAS, KRAS) were found to be involved in HNSCC.…”